Status:
COMPLETED
Surfactant Replacement Guided by Early Lung Ultrasound Score in Preterm Newborns With Respiratory Distress Syndrome
Lead Sponsor:
Centre Hospitalier Universitaire de Saint Etienne
Conditions:
Preterm Birth
Eligibility:
All Genders
Up to 1 years
Brief Summary
Lung immaturity is a major issue in neonatal unit.The surfactant administration improves the pulmonary prognosis in premature infants with hyaline membrane disease who escape continuous positive airwa...
Detailed Description
This current study analyzes the impact of early Lungs Ultrasounds which use a semi-quantitative assessment : the Lung Ultrasound Score (LUS), in preterms \<33 weeks on the time to surfactant administr...
Eligibility Criteria
Inclusion
- newborns \<33 weeks old
- born at the Saint Etienne University Hospital
- respiratory distress syndrome
Exclusion
- chromosomal abnormality,
- multi-polymalformations syndrome,
- congenital pulmonary disease,
- septic shock,
- congenital lung infection,
- meconium inhalation,
- pneumothorax
- conditions requiring surgery in the first week of life.
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 31 2021
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT04775459
Start Date
January 1 2021
End Date
May 31 2021
Last Update
June 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu de Saint-Etienne
Saint-Etienne, France, 42055